ICMR approval: India okays use of FDC Kaletra to treat Covid; Hospitalised adult patients with laboratory confirmed SARS CoV-2 infection can give written informed consent to receive the treatment for 14 days.

Basın/Medya: Press/Media

Periyot25 Mar 2020

Media coverage

1

Media coverage

  • BaşlıkICMR approval: India okays use of FDC Kaletra to treat Covid; Hospitalised adult patients with laboratory confirmed SARS CoV-2 infection can give written informed consent to receive the treatment for 14 days.
    Medya adı/satış noktasıThe Financial Express
    ÜlkeIndia
    Tarih25/03/20
    KişilerNivedita Gupta